Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 16,005 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 16,005 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $30.00, for a total value of $480,150.00. Following the transaction, the chief operating officer now directly owns 748,302 shares in the company, valued at $22,449,060. This represents a 2.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Evan Roberts also recently made the following trade(s):

• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The shares were sold at an average price of $30.06, for a total value of $105,781.14.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total value of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Stock Performance

Shares of PHR stock opened at $28.49 on Friday. The company has a market capitalization of $1.66 billion, a P/E ratio of -19.38 and a beta of 0.96. The business’s 50 day moving average is $27.22 and its two-hundred day moving average is $23.80. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.58) earnings per share. Analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Citigroup increased their price objective on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Friday, January 10th. KeyCorp increased their price objective on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Finally, Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Thirteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $31.15.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently bought and sold shares of the business. Invesco Ltd. boosted its position in Phreesia by 0.9% during the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company’s stock worth $1,013,000 after purchasing an additional 357 shares in the last quarter. NewEdge Advisors LLC boosted its position in Phreesia by 12.1% during the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company’s stock worth $107,000 after purchasing an additional 459 shares in the last quarter. Johnson Financial Group Inc. lifted its position in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of Phreesia by 3.3% in the third quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock valued at $637,000 after acquiring an additional 905 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its position in shares of Phreesia by 3.8% in the third quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock valued at $701,000 after acquiring an additional 1,120 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.